BIONET Therapeutics Corp.

NT$33.65As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7808Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (6.87%)
Biological Products, Except Diagnostic Substances
Beta (5Y) —
PE TTM —
TSR TTM (47.01%)
Mkt cap NT$2.356B
ROIC (5.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$40
19.59%
(19.32%)
Hold 12|1|5|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.43
0.48
0.53
0.55
26.78%
36.76%
38.47%
30.67%
RevenueNT$M
177.7
184.4
191.1
189.3
17.13%
17.92%
16.32%
11.17%
Peers (US$71.14M)
Cap (US$)
PE
34.79M
—
Capital
TTM
5Y
10Y
Leveragex
0.230
0.184
0.146
EBIT/Intx
0.340
0.479
0.493
Own earn%
(310.77)
52.23
56.42
Sh yield%
48.33
45.82
47.85
Owners
Insiders/Inst%
11.06
89.02
Short interest%
5.64
SBC / revenue%
0.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
16–22
$1 testx
—
Incr. ROIC%
5